ID   A0A8B8THC2_CAMFR        Unreviewed;       858 AA.
AC   A0A8B8THC2;
DT   19-JAN-2022, integrated into UniProtKB/TrEMBL.
DT   19-JAN-2022, sequence version 1.
DT   05-FEB-2025, entry version 15.
DE   RecName: Full=GMP synthase (glutamine-hydrolyzing) {ECO:0000256|ARBA:ARBA00012746};
DE            EC=6.3.5.2 {ECO:0000256|ARBA:ARBA00012746};
DE   AltName: Full=Glutamine amidotransferase {ECO:0000256|ARBA:ARBA00031356};
GN   Name=GMPS {ECO:0000313|RefSeq:XP_032341626.1};
OS   Camelus ferus (Wild bactrian camel) (Camelus bactrianus ferus).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Tylopoda; Camelidae; Camelus.
OX   NCBI_TaxID=419612 {ECO:0000313|Proteomes:UP000694856, ECO:0000313|RefSeq:XP_032341626.1};
RN   [1] {ECO:0000313|RefSeq:XP_032341626.1}
RP   IDENTIFICATION.
RC   TISSUE=Ear skin {ECO:0000313|RefSeq:XP_032341626.1};
RG   RefSeq;
RL   Submitted (OCT-2024) to UniProtKB.
CC   -!- PATHWAY: Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln
CC       route): step 1/1. {ECO:0000256|ARBA:ARBA00005153}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   RefSeq; XP_032341626.1; XM_032485735.1.
DR   KEGG; cfr:102509770; -.
DR   UniPathway; UPA00189; UER00296.
DR   Proteomes; UP000694856; Chromosome 1.
DR   GO; GO:0005829; C:cytosol; IEA:TreeGrafter.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003921; F:GMP synthase activity; IEA:InterPro.
DR   GO; GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-UniRule.
DR   CDD; cd01742; GATase1_GMP_Synthase; 1.
DR   CDD; cd01997; GMP_synthase_C; 1.
DR   FunFam; 3.30.300.10:FF:000008; GMP synthase [glutamine-hydrolyzing]; 1.
DR   FunFam; 3.30.300.10:FF:000009; GMP synthase [glutamine-hydrolyzing]; 1.
DR   FunFam; 3.40.50.620:FF:000044; GMP synthase [glutamine-hydrolyzing]; 1.
DR   FunFam; 3.40.50.880:FF:000013; GMP synthase [glutamine-hydrolyzing]; 1.
DR   Gene3D; 3.30.300.10; -; 2.
DR   Gene3D; 3.40.50.880; -; 1.
DR   Gene3D; 3.40.50.620; HUPs; 1.
DR   InterPro; IPR029062; Class_I_gatase-like.
DR   InterPro; IPR017926; GATASE.
DR   InterPro; IPR001674; GMP_synth_C.
DR   InterPro; IPR004739; GMP_synth_GATase.
DR   InterPro; IPR025777; GMPS_ATP_PPase_dom.
DR   InterPro; IPR022310; NAD/GMP_synthase.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   NCBIfam; TIGR00888; guaA_Nterm; 1.
DR   PANTHER; PTHR11922:SF2; GMP SYNTHASE [GLUTAMINE-HYDROLYZING]; 1.
DR   PANTHER; PTHR11922; GMP SYNTHASE-RELATED; 1.
DR   Pfam; PF00117; GATase; 1.
DR   Pfam; PF00958; GMP_synt_C; 1.
DR   Pfam; PF02540; NAD_synthase; 1.
DR   PRINTS; PR00097; ANTSNTHASEII.
DR   PRINTS; PR00096; GATASE.
DR   SUPFAM; SSF52402; Adenine nucleotide alpha hydrolases-like; 1.
DR   SUPFAM; SSF52317; Class I glutamine amidotransferase-like; 1.
DR   SUPFAM; SSF54810; GMP synthetase C-terminal dimerisation domain; 2.
DR   PROSITE; PS51273; GATASE_TYPE_1; 1.
DR   PROSITE; PS51553; GMPS_ATP_PPASE; 1.
PE   4: Predicted;
KW   ATP-binding {ECO:0000256|ARBA:ARBA00022840, ECO:0000256|PROSITE-
KW   ProRule:PRU00886};
KW   Glutamine amidotransferase {ECO:0000256|ARBA:ARBA00022962,
KW   ECO:0000256|PROSITE-ProRule:PRU00605};
KW   GMP biosynthesis {ECO:0000256|ARBA:ARBA00022749, ECO:0000256|PROSITE-
KW   ProRule:PRU00886}; Ligase {ECO:0000256|ARBA:ARBA00022598};
KW   Nucleotide-binding {ECO:0000256|ARBA:ARBA00022741, ECO:0000256|PROSITE-
KW   ProRule:PRU00886};
KW   Purine biosynthesis {ECO:0000256|ARBA:ARBA00022755, ECO:0000256|PROSITE-
KW   ProRule:PRU00886}.
FT   DOMAIN          382..600
FT                   /note="GMPS ATP-PPase"
FT                   /evidence="ECO:0000259|PROSITE:PS51553"
FT   REGION          1..89
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          125..148
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        130..148
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        269
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00605"
FT   ACT_SITE        355
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00605"
FT   ACT_SITE        357
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00605"
FT   BINDING         409..415
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00886"
SQ   SEQUENCE   858 AA;  92864 MW;  A66B93F9A595D2E5 CRC64;
     MTGVGRGQTP QDPPLRGGQA GDARVSSPGA GLGGGGDGPG GGASRRSPHL RRRAYLVAAA
     AGGVPAARQP RQTGSGSSQW PAGAEAGGGG SVRAAGLFSR GAGARAPRLL LESALRRRPA
     LLRAARPPAS YSTRPPSQSW PVASTPPTLS RPVSSLAAAT AAPAPMALCN GDSKLENAGG
     DLKDGHHHYE GAVVILDAGA QYGKVIDRRV RELFVQSEIF PLETPAFAIK EQGFRAIIIS
     GGPNSVYAED APWFDPAIFT IGKPVLGICY GMQMMNKVFG GTVHKKSVRE DGVFSVSVDN
     TCSLFRGLQK EEIVLLTHGD SVDKVADGFK VVARSGNIVA GIANESKKLY GAQFHPEVGL
     TENGKVILKN FLYDIAGCSG TFTVQNRELE CIREIKERVG TSKVLVLLSG GVDSTVCTAL
     LNRALNQDQV IAVHIDNGFM RKRESQSVEE ALKKLGIQVK VINAAHSFYN GTTTLPISDE
     DRTPRKRISK TLNMTTSPEE KRKIIGDTFV KIANEVIGEM NLKPEEVFLA QGTLRPDLIE
     SASLVASGKA ELIKTHHNDT ELIRKLREEG KVIEPLKDFH KDEVRILGRE LGLPEELVSR
     HPFPGPGLAI RVICAEEPYI CKDFPETNNI LKIVADFSAS VKKPHTLLQR VKACTTEEDQ
     EKLMQITSLH SLNAFLLPIK TVGVQGDCRS YSYVCGISSK DEPDWESLIF LARLIPRMCH
     NINRVVYIFG PPVKEPPTDV TPTFLTTGVL STLRQADFEA HNILRESGYA GKISQMPVIL
     TPLHFDRDPL QKQPSCQRSV VIRTFITSDF MTGIPATPGN EIPVEVVLKM VTEIKKIPGI
     SRIMYDLTSK PPGTTEWE
//
